RU94016980A - Enterosorbent for renal failure therapy
- Google Patents
Enterosorbent for renal failure therapy
Info
Publication number
RU94016980A
RU94016980ARU94016980/14ARU94016980ARU94016980ARU 94016980 ARU94016980 ARU 94016980ARU 94016980/14 ARU94016980/14 ARU 94016980/14ARU 94016980 ARU94016980 ARU 94016980ARU 94016980 ARU94016980 ARU 94016980A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Институт биохимии СОРАМНfiledCriticalИнститут биохимии СОРАМН
Priority to RU94016980/14ApriorityCriticalpatent/RU2097046C1/en
Publication of RU94016980ApublicationCriticalpatent/RU94016980A/en
Application grantedgrantedCritical
Publication of RU2097046C1publicationCriticalpatent/RU2097046C1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
FIELD: medicine, nephrology. SUBSTANCE: natural zeolite-containing tuff (clinoptilolite) is proposed as an enterosorbent showing effectiveness for conservative therapy of acute, progressive and chronic renal failure of different etiology. EFFECT: enterosorbent assortment making. 5 tbl, 2 dwg, 4 ph, 3 cl
Claims (1)
Изобретение относится к медицине, в частности к нефрологии. Задача изобретения - формирование ассортимента энтеросорбентов, эффективных для консервативной терапии острой, прогрессирующей и хронической почечной недостаточности различной этиологии. Природный цеолитсодержащий туф (клиноптилолит) предложен в качестве такого энтеросорбента. 1 н. и 2 з.п. ф-лы.The invention relates to medicine, in particular to nephrology. The objective of the invention is the formation of an assortment of enterosorbents effective for conservative therapy of acute, progressive and chronic renal failure of various etiologies. Natural zeolite-containing tuff (clinoptilolite) is proposed as such an enterosorbent. 1 n and 2 z.p. f-ly.
RU94016980/14A1994-05-111994-05-11Enterosorbent for treating renal insufficiency
RU2097046C1
(en)
Use of bactericidal/permeability increasing protein or biologically active analogs thereof to treat lipopolysaccharide associated gram negative infections
PROCESS FOR THE IMMUNOLOGICAL DETERMINATION OF HEPARANOSULFATE-PROTEOGLYCANE, PROCESS FOR THE PREPARATION OR FOR THE PURIFICATION OF HEPARANOSULFATE-PROTEOGLYCANE PROPERLY APPROVED FROM THE TABLES CONTAINING BASIC MEMBRANES